Article
CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the…
medRxiv · 2022 · Archana Bommi-Reddy
Key facts
| Title | CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells |
|---|---|
| First author | Archana Bommi-Reddy |
| Journal | medRxiv |
| Published | Jan 3, 2022 |
| DOI | 10.1101/2021.12.26.474204 |
| Devices mentioned | K010696 |
| Product codes mentioned | JIS, JJH, JJX, MVU, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1